To establish the clinical relevance of these results and to specify the relevant signaling pathway in vivo we analyzed the integrin α5 expression and the activity of ERK and AKT in a cohort of 141 ccRCC specimens. The gene discussed is MAPK1; the disease is nonpapillary renal cell carcinoma.